Table 5. Incremental Cost-Effectiveness Ratio (ICER)*.
treatment options | Total cost ($) | Total effect (QALYs) | incrCost ($) | incrEff (QALYs) | ICER ($/QALY) | ICER ($/LY) |
placebo | $75,366 | 0.43 | 0 | 0 | 0 | 0 |
mitoxantrone | $83,171 | 0.51 | 7,805 | 0.08 | $100,675 | $34,677 |
abiraterone | $101,050 | 0.70 | 17,880 | 0.20 | $91,188 | $61,182 |
cabazitaxel | $156,140 | 0.76 | 55,089 | 0.06 | $955,863 | $400,046 |
The analysis was conducted by using DATA software version TreeAge Pro 2012 (TreeAge, Williamstown, MA).
Costs are in 2010 US dollars.